News
Joint Development between KIST Europe and EU Joint Research Center on (2020.05.13)
- Date : 2020-05-15
- Views : 2785
-
Writer
International Cooperation Team
-
Att.
Joint Development between KIST Europe and EU Joint Research Center on COVID-19 AOPs
KIST Europe has
launched a research consultative group to investigate Adverse Outcome Pathways
(AOPs) for COVID-19 in the human body in conjunction with the European Union
Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM), an agency
involved with the verification and evaluation of alternatives to animal testing
methods under the Joint Research Center (JRC) of the European Union.
In 2019, KIST
Europe developed a total of five new AOPs and applied for their registration
with the Organization for Economic Cooperation and Development (OECD), with
three being selected for inclusion in the OECD Work Plan. In addition, in
response to the spread of COVID-19 earlier this year, KIST Europe filed a new
AOP exclusively for identifying the outcome pathway of COVID-19 in the human
body, and agreed to further develop specific pathways and verify them as AOPs
filed with the EURL ECVAM under the JRC.
The formation of a
joint development research consultative group was discussed in detail following
EURL ECVAM learning about the COVID-19 AOP from KIST Europe and sounding out
the possibility for joint development and cooperation. In the future, the
research consultative group will take the first steps to beginning a
full-fledged research effort by defining the roles of each participating
organization.
KIST Europe
selected as its main research area “development of a framework for an endocrine
disruptor AOP in the ecosystem,” and, based on its accumulated experiences in
the field of environmental safety since 2018, has been analyzing the
competitiveness of existing capacities and the possibility of research
promotion in Europe through an evaluation committee consisting of internal and
external experts. In addition, KIST Europe has been conducting research
undertakings related to the Creative Convergence Research Project (CAP) with
support from the National Research Council of Science & Technology (NST).
Related link:
https://www.etnews.com/20200506000209